Mitchell Levine

2019

In 2019, Mitchell Levine earned a total compensation of $1.2M as Chief Financial Officer at Oncocyte Corp, a 33% increase compared to previous year.

Compensation breakdown

Bonus$131,670
Option Awards$600,142
Salary$343,063
Stock Awards$70,400
Other$12,662
Total$1,157,937

Levine received $600.1K in option awards, accounting for 52% of the total pay in 2019.

Levine also received $131.7K in bonus, $343.1K in salary, $70.4K in stock awards and $12.7K in other compensation.

Rankings

In 2019, Mitchell Levine's compensation ranked 8,599th out of 13,971 executives tracked by ExecPay. In other words, Levine earned more than 38.5% of executives.

ClassificationRankingPercentile
All
8,599
out of 13,971
39th
Division
Manufacturing
3,413
out of 5,695
40th
Major group
Chemicals And Allied Products
1,293
out of 2,194
41st
Industry group
Drugs
1,100
out of 1,880
42nd
Industry
In Vitro and In Vivo Diagnostic Substances
32
out of 77
58th
Source: SEC filing on May 26, 2020.

Levine's colleagues

We found five more compensation records of executives who worked with Mitchell Levine at Oncocyte Corp in 2019.

2019

Ronald Andrews

Oncocyte Corp

Chief Executive Officer

2019

William Annett

Oncocyte Corp

Chief Executive Officer

2019

Lyndal Hesterberg

Oncocyte Corp

Chief Scientific Officer

2019

Albert Parker

Oncocyte Corp

Chief Operating Officer

2019

Padma Sundar

Oncocyte Corp

Senior Vice President, Marketing and Market Access

News

In-depth

You may also like